Research Study: JenaVAD
Condition:
Heart Valve Disease, Aortic Regurgitation
Study Sponsor:
JenaValve Technology
Study Investigator:
Dr. Konstantinos Voudris
Study Contact:
Every research study comes with its own unique risks and benefits; the study team will assess whether you’re an eligible candidate and ensure you’re provided with all the information you need to decide if participating is right for you.
About this Study:
To evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated for TAVR.
